Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Rheological Effects of L-Glutamine in Patients with Sickle Cell Disease

Celeste K. Kanne, BA, Varun Reddy, Vivien A. Sheehan, MD PhD

Blood (2019) 134 (Supplement_1): 3567.

https://doi.org/10.1182/blood-2019-128891

Published: 2019

Journal Articles

Geranylgeranyl Diphosphate Synthase Inhibitor and Proteasome Inhibitor Combination Therapy in Multiple Myeloma

Staci L. Haney, PhD, Michelle L. Varney, MS, Lynette M. Smith, PhD, Sarah A. Holstein, MD PhD

Blood (2019) 134 (Supplement_1): 4417.

https://doi.org/10.1182/blood-2019-129244

Published: 2019

Journal Articles

FoxM1-Mediated Signaling Promotes the Progression of Mantle Cell Lymphoma

Hui Guo, PhD, Yixin Yao, PhD, Hui Zhang, Elizabeth Lorence, Makhdum Ahmed, MD PhD MPH, Lingyan Ping, MD PhD, Krystle Nomie, PhD, Liang Zhang, MD PhD, Michael Wang, MD

Blood (2018) 132 (Supplement 1): 4176.

https://doi.org/10.1182/blood-2018-99-119349

Published: 2018

Journal Articles

Platelet Apoptosis and PAI-1 Content Are Involved in the Procoagulant Profile of Immune Thrombocytopenia Patients Responders to Agonists of Thrombopoietin Receptor.

Raul Justo Sanz, Elena Monzón Manzano, Ihosvany Fernandez-Bello, Teresa Álvarez-Roman, Mónica Martín, María Isabel Rivas Pollmar, Miguel A. Canales, Victor Jimenez-Yuste, Nora Butta, PhD

Blood (2018) 132 (Supplement 1): 3738.

https://doi.org/10.1182/blood-2018-99-115898

Published: 2018

Journal Articles

Mitochondria-Targeted Effects of Water-Soluble Polyol-Methanofullerenes on Human Whole Blood Platelets, Lymphocytes and Granulocytes Ex Vivo

Gulzada Tarasova, PhDstudent, Natalia Kalacheva, PhD, Guzel Fazleeva, PhD, Valentina Gubskaya, PhD, Albert Rizvanov, DSc, PhD, Georgi Cherepnev, MD PhD

Blood (2017) 130 (Supplement 1): 4836.

https://doi.org/10.1182/blood.V130.Suppl_1.4836.4836

Published: 2017

Journal Articles

FoxM1: A New Therapeutic Target for Mantle Cell Lymphoma

Hui Guo, MD PhD, Hui Zhang, Makhdum Ahmed, MD MPH, PhD, Yang Liu, MD, Shengjian Huang, PhD, Victoria Zhang, Jeffrey Wang, Elyse Lopez, Elizabeth A Lorence, MPH, Jacqueline Wang, Swathi Balaji, Merolle Maria, Changying Jiang, PhD, Krystle Nomie, PhD, Michael Wang, BS, Liang Zhang, MD PhD

Blood (2017) 130 (Supplement 1): 1469.

https://doi.org/10.1182/blood.V130.Suppl_1.1469.1469

Published: 2017

Journal Articles

Androgen Receptor Overexpression in Mantle Cell Lymphoma: Potential Novel Therapeutic Implications

Paul S Martin, MD, Elahe Mostaghel, MD PhD, Stephen Mongovin, Shani L. Frayo, Ailin Zhang, Kerstin Lara Edlefsen, MD, Oliver W Press, MD PhD, Ajay K. Gopal, MD

Blood (2016) 128 (22): 3014.

https://doi.org/10.1182/blood.V128.22.3014.3014

Published: 2016

Journal Articles

Valproic Acid Expands the Numbers of HSCs from Cord Blood CD34 + Cells By Linking Epigenetic Modifications to Mitochondrial Remodeling and p53 Upregulation

Luena Papa, Eran Zimran, MD, Mansour Djedaini, BS, Ronald Hoffman, MD

Blood (2016) 128 (22): 369.

https://doi.org/10.1182/blood.V128.22.369.369

Published: 2016

Journal Articles

CAR-Engineered T Cells Specific for the Elotuzumab Target SLAMF7 Eliminate Primary Myeloma Cells and Confer Selective Fratricide of SLAMF7+ Normal Lymphocyte Subsets

Sophia Danhof, MD, Tea Gogishvili, PhD, Silvia Koch, Martin Schreder, MD, Stefan Knop, Hermann Einsele, Michael Hudecek, MD

Blood (2015) 126 (23): 115.

https://doi.org/10.1182/blood.V126.23.115.115

Published: 2015

Journal Articles

The Combination of the Novel Syk Inhibitor TAK659 with Decitabine Exerts Synergistic Cytotoxic Effects Against FLT3/ITD Mutated Acute Myeloid Leukemia Cells

Edwin Stage, MS, Magdalena Czader, MD PhD, Heather O'Leary, PhD, H. Scott Boswell, MD, Larry D. Cripe, MD, Hamid Sayar, MD, Cedric Dos Santos, PhD, Mark J. Levis, MD PhD, Heiko Konig, MDPhD

Blood (2015) 126 (23): 4928.

https://doi.org/10.1182/blood.V126.23.4928.4928

Published: 2015

Journal Articles

Sample Processing Obscures Cancer-Specific Alterations in Leukemic Transcriptomes

Heidi Dvinge, PhD, Rhonda E. Ries, MA, Janine O. Ilagan, PhD, Derek L. Stirewalt, MD, Soheil Meshinchi, MD PhD, Robert K. Bradley, PhD

Blood (2014) 124 (21): 2201.

https://doi.org/10.1182/blood.V124.21.2201.2201

Published: 2014

Journal Articles

In-Vitro Actvity of Pixantrone (PIX) in Plasma Cell Leukaemia (PCL) and Early Clinical Activity in a Pixantrone–Pomalidomide–Dexamethasone (PiPoD) Combination

Ella Willenbacher, MD, Wolfgang Willenbacher, MD, Gunther Gastl, Prof., Dr., Irmgard Verdorfer, MDPhD, Brigitte Kircher, PhD

Blood (2014) 124 (21): 5732.

https://doi.org/10.1182/blood.V124.21.5732.5732

Published: 2014

Journal Articles

Targeting The Protective Microenvironment In Multiple Myeloma (MM): An Analysis Of The CXCL12/CXCR4-Axis and Its Inhibitors AMD3100 and Nox-A12 Combined With Antimyeloma Substances, Such As Pomalidomide and Carfilzomib

Anna Simon, Dagmar Wider, Marie Follo, PhD, Johannes Waldschmidt, Martina Kleber, Ralph Waesch, MD, Monika Engelhardt, MD

Blood (2013) 122 (21): 3851.

https://doi.org/10.1182/blood.V122.21.3851.3851

Published: 2013

Journal Articles

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Blood (2013) 122 (21): 1294.

https://doi.org/10.1182/blood.V122.21.1294.1294

Published: 2013

Journal Articles

RASA3 Plays a Critical, Conserved Role in Erythroid Differentiation

Lionel Blanc, PhD, Steven L. Ciciotte, MS, Jeffrey Michael Lipton, MD, PhD, Johnson M. Liu, MD, Luanne L. Peters, PhD

Blood (2012) 120 (21): 3186.

https://doi.org/10.1182/blood.V120.21.3186.3186

Published: 2012

Journal Articles

Antibodies Specific for MHC Class II Antigens Cause TRALI Directly in a Two-Event in Vivo Model

Marguerite R Kelher, MS, Christopher C. Silliman, MD, PhD

Blood (2012) 120 (21): 845.

https://doi.org/10.1182/blood.V120.21.845.845

Published: 2012

Journal Articles

Preclinical Characterization of KB003, a Novel Humaneered™ Monoclonal Anti-GM-CSF Antibody, Demonstrates That the GM-CSF Signaling Axis Is a Therapeutic Target in Chronic Myelomonocytic Leukemia (CMML)

Eric Padron, MD, Jeffrey S Painter, BS, Adam W Mailloux, PhD, Kathy L. McGraw, Jessica M. McDaniel, BS, Christopher Bebbington, DPhil., Mark Baer, PhD, Geoffrey Yarranton, PhD, Jeffrey E Lancet, MD, Rami S. Komrokji, MD, Alan F. List, MD, P.K. Epling-Burnette, PharmD, PhD

Blood (2012) 120 (21): 3793.

https://doi.org/10.1182/blood.V120.21.3793.3793

Published: 2012

Journal Articles

Hypomethylating Agents Correct Subcellular Localization of FOXO3a and (re)Establish Expression of Its Transcriptional Targets In AML and MDS- Cells

Sylvain Thepot, Elodie Lainey, Marie Sebert, Lionel Ades, Claude Gardin, Pierre Fenaux, MD, PhD, Guido Kroemer, Simone Boehrer

Blood (2010) 116 (21): 2173.

https://doi.org/10.1182/blood.V116.21.2173.2173

Published: 2010

Journal Articles

Phosphatase RNA-Interference Lethality Screening with Suberoylanilide Hyrdoxamic Acid In Myeloid Cell Lines

James Bogenberger, Michelle Kassner, Donald Chow, Holly Yin, Raoul Tibes

Blood (2010) 116 (21): 1851.

https://doi.org/10.1182/blood.V116.21.1851.1851

Published: 2010

Journal Articles

A Novel, Colorimetric Platelet Activation Assay for Diagnosis of Heparin Induced Thrombocytopenia

M. Margaret Prechel, PhD, Vicki Escalante, BS, Amanda F. Drenth, BS, Jeanine M. Walenga, PhD

Blood (2010) 116 (21): 5127.

https://doi.org/10.1182/blood.V116.21.5127.5127

Published: 2010

NARROW

Rheological Effects of L-Glutamine in Patients with Sickle Cell Disease

Geranylgeranyl Diphosphate Synthase Inhibitor and Proteasome Inhibitor Combination Therapy in Multiple Myeloma

FoxM1-Mediated Signaling Promotes the Progression of Mantle Cell Lymphoma

Platelet Apoptosis and PAI-1 Content Are Involved in the Procoagulant Profile of Immune Thrombocytopenia Patients Responders to Agonists of Thrombopoietin Receptor.

Mitochondria-Targeted Effects of Water-Soluble Polyol-Methanofullerenes on Human Whole Blood Platelets, Lymphocytes and Granulocytes Ex Vivo

FoxM1: A New Therapeutic Target for Mantle Cell Lymphoma

Androgen Receptor Overexpression in Mantle Cell Lymphoma: Potential Novel Therapeutic Implications

Valproic Acid Expands the Numbers of HSCs from Cord Blood CD34 + Cells By Linking Epigenetic Modifications to Mitochondrial Remodeling and p53 Upregulation

CAR-Engineered T Cells Specific for the Elotuzumab Target SLAMF7 Eliminate Primary Myeloma Cells and Confer Selective Fratricide of SLAMF7+ Normal Lymphocyte Subsets

The Combination of the Novel Syk Inhibitor TAK659 with Decitabine Exerts Synergistic Cytotoxic Effects Against FLT3/ITD Mutated Acute Myeloid Leukemia Cells

Sample Processing Obscures Cancer-Specific Alterations in Leukemic Transcriptomes

In-Vitro Actvity of Pixantrone (PIX) in Plasma Cell Leukaemia (PCL) and Early Clinical Activity in a Pixantrone–Pomalidomide–Dexamethasone (PiPoD) Combination

Targeting The Protective Microenvironment In Multiple Myeloma (MM): An Analysis Of The CXCL12/CXCR4-Axis and Its Inhibitors AMD3100 and Nox-A12 Combined With Antimyeloma Substances, Such As Pomalidomide and Carfilzomib

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

RASA3 Plays a Critical, Conserved Role in Erythroid Differentiation

Antibodies Specific for MHC Class II Antigens Cause TRALI Directly in a Two-Event in Vivo Model

Preclinical Characterization of KB003, a Novel Humaneered™ Monoclonal Anti-GM-CSF Antibody, Demonstrates That the GM-CSF Signaling Axis Is a Therapeutic Target in Chronic Myelomonocytic Leukemia (CMML)

Hypomethylating Agents Correct Subcellular Localization of FOXO3a and (re)Establish Expression of Its Transcriptional Targets In AML and MDS- Cells

Phosphatase RNA-Interference Lethality Screening with Suberoylanilide Hyrdoxamic Acid In Myeloid Cell Lines

A Novel, Colorimetric Platelet Activation Assay for Diagnosis of Heparin Induced Thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only